These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6809629)

  • 21. Meningococcal vaccines. Current status and future possibilities.
    Peltola H
    Drugs; 1998 Mar; 55(3):347-66. PubMed ID: 9530542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.
    Liu MA; Friedman A; Oliff AI; Tai J; Martinez D; Deck RR; Shieh JT; Jenkins TD; Donnelly JJ; Hawe LA
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4633-7. PubMed ID: 1533934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
    Granoff DM; Gupta RK; Belshe RB; Anderson EL
    J Infect Dis; 1998 Sep; 178(3):870-4. PubMed ID: 9728562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease.
    Moe GR; Tan S; Granoff DM
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):209-26. PubMed ID: 10575132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.
    Choo S; Zuckerman J; Goilav C; Hatzmann E; Everard J; Finn A
    Vaccine; 2000 Jun; 18(24):2686-92. PubMed ID: 10781855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.
    Beuvery EC; Miedema F; van Delft R; Haverkamp J
    Infect Immun; 1983 Apr; 40(1):39-45. PubMed ID: 6187693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.
    Wedege E; Høiby EA; Rosenqvist E; Bjune G
    Infect Immun; 1998 Jul; 66(7):3223-31. PubMed ID: 9632589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children.
    King WJ; MacDonald NE; Wells G; Huang J; Allen U; Chan F; Ferris W; Diaz-Mitoma F; Ashton F
    J Pediatr; 1996 Feb; 128(2):196-202. PubMed ID: 8636811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model.
    Craven DE; Frasch CE
    Infect Immun; 1979 Oct; 26(1):110-7. PubMed ID: 115794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospects for the prevention of meningococcal disease: special reference to group B.
    Frasch CE
    Vaccine; 1987 Mar; 5(1):3-4. PubMed ID: 3107234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents.
    Zhang Q; Choo S; Everard J; Jennings R; Finn A
    Infect Immun; 2000 May; 68(5):2692-7. PubMed ID: 10768961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of meningococcal group B vaccine candidates: capsular or noncapsular?
    Diaz Romero J; Outschoorn IM
    Clin Microbiol Rev; 1994 Oct; 7(4):559-75. PubMed ID: 7834605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotype determinant protein of Neisseria Meningitidis. Large scale preparation by direct detergent treatment of the bacterial cells.
    Helting TB; Guthöhrlein G; Blackkolb F; Ronneberger H
    Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):69-78. PubMed ID: 6794337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses.
    Granoff DM; Maslanka SE; Carlone GM; Plikaytis BD; Santos GF; Mokatrin A; Raff HV
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):479-85. PubMed ID: 9665952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunogenic and protective properties of meningococcal serotype 2a protein in the hen-embryo model.
    Ashton FE; Ryan JA; Diena BB; Frasch CE
    J Med Microbiol; 1983 Nov; 16(4):443-57. PubMed ID: 6417339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human opsonins to meningococci after vaccination.
    Halstensen A; Haneberg B; Frøholm LO; Lehmann V; Frasch CE; Solberg CO
    Infect Immun; 1984 Dec; 46(3):673-6. PubMed ID: 6437988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.
    Twumasi PA; Kumah S; Leach A; O'Dempsey TJ; Ceesay SJ; Todd J; Broome CV; Carlone GM; Pais LB; Holder PK
    J Infect Dis; 1995 Mar; 171(3):632-8. PubMed ID: 7876610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.